Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer with high
mortality. The realization of precision medicine in HCC relies upon efficient biomarkers …

The most commonly used clinical methods are enzyme-linked immunosorbent assay
(ELISA) and quantitative PCR (qPCR) in which ELISA was applied for the detection of …

Abstract Background Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is an
efficient biomarker specific for hepatocellular carcinoma (HCC). Some researchers have …

Aim Hepatocellular carcinoma (HCC) is the second leading cause of cancer mortality
worldwide. An excess of iron in liver tissue causes oxidative stress, leading to hepatocellular …

BACKGROUND Researchers have investigated the diagnostic value of protein induced by
vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP) in hepatitis B virus …

Simple Summary The ideal treatment for hepatocellular carcinoma (HCC) is liver
transplantation (LT), which both eliminates the HCC and cures the diseased liver. Once …

The Milan criteria (MC) remain the cornerstone for the selection of patients with
hepatocellular cancer (HCC) to be listed for liver transplantation (LT). Recently, several …

Liver transplantation (LT) is the only potentially curative treatment for selected patients with
cirrhosis and hepatocellular carcinoma (HCC) who are not candidates for resection. When …

The incidence of hepatocellular carcinoma (HCC) is increasing, despite effective antiviral
treatment for hepatitis B (HBV) and C virus infection and the application of preventive …

Background N6-methyladenosine (m6A), the most internal mRNA modification, is involved in
various cancers. However, the function of m6A in hepatocellular carcinoma (HCC) is still not …